Independent Portfolio Consultants’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
OAG
Independent Portfolio Consultants's ELV Position: Q2 2017 in Review
Independent Portfolio Consultants reduced its Elevance Health (ELV) stake by 29% in Q2 2017, selling an estimated $192K and leaving 2,625 shares worth $494K. The position accounts for 0.2% of the portfolio, ranked #164.
Independent Portfolio Consultants first reported a position in ELV in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.12M in Q1 2015. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.
- Independent Portfolio Consultants held 2,625 shares of Elevance Health worth $494K as of Q2 2017.
- Independent Portfolio Consultants sold 1,069 Elevance Health shares in Q2 2017, an estimated $192K.
- Elevance Health made up 0.2% of Independent Portfolio Consultants's portfolio in Q2 2017, its #164 holding.
- Independent Portfolio Consultants first reported a position in Elevance Health in Q2 2013 and has held it in 17 quarters since.
- Independent Portfolio Consultants's Elevance Health position peaked at $1.12M in Q1 2015.
- 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.
Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.